Background
==========

In 1996, the Brazilian National Tuberculosis Control Program (NTCP) incorporated the directly observed treatment strategy (DOTS) for reaching World Health Organization (WHO) cure targets and reducing default rates, thus preventing emergence of resistant bacillus \[[@B1]\]. In the following years, as in other countries that recommended DOTS, a decrease in default rates and an increment in case detection and cure rates were observed in Brazil. Nevertheless, this was insufficient to achieve the target for tuberculosis control in the country \[[@B2],[@B3]\].

By the end of 2009, Brazil was the only high-burden country to use a treatment regimen with only three drugs \[fixed-dose combination (FDC)-Rifampin and Isoniazid (RH) and Pyrazinamide (Z)\]. Despite a free-of-charge treatment, the default rates were around 9.3%, attaining 14% in some states \[[@B4]\]. At this point, the NTCP advisory board revised the Brazilian Tuberculosis Guidelines and recommended the WHO-suggested four-drug FDC regimen for tuberculosis treatment for adolescents and adults (over 10 years old). Besides including Ethambutol (E), the new regimen reduced doses of H (from 400 to 300 mg) and of Z (from 2000 to 1600 mg). The new FDC-RHZE regimen was expected to result in lower default rates and higher effectiveness of treatment. The rational was that the smaller number of pills to be taken and the better tolerance due to dose reduction would increase adherence to treatment \[[@B5]\]. Finally, the NTCP expected that the inclusion of a fourth drug would fight the emergence of resistance, which was, at that point, widely spread in Eastern Europe, Asia and Africa \[[@B6]\].

According to the Brazilian Ministry of Health (MoH), the implementation of the FDC-RHZE regimen has followed a schedule set by the NTCP in agreement with the Brazilian states' programs \[[@B5]\]. The use of this regimen started in the North (Amazonian) region, which had the highest incidence rate until the 90's, while the Southeast region, presently with the highest disease burden, was the last one to implement the new regimen \[[@B7]\]. The effective use of the new regimen may have faced important barriers in healthcare services, such as poor adhesion by professionals and by tuberculosis patients.

New tuberculosis treatment regimens and diagnostic technologies in the health system are expected during the following years \[[@B8]-[@B12]\]. Understanding the barriers and bottlenecks that could delay the incorporation of these technologies may be useful for the NTCP stakeholders. In Brazil, several public health programs \[[@B8]-[@B12]\], including DOTS \[[@B13]\], had their implementation process investigated. However, no published studies on the implementation process of the recently adopted therapeutic regimen for tuberculosis were found in the literature.

The objective of the present study is to investigate socio-demographic, epidemiological and operational factors associated with the implementation process of the FDC-RHZE regimen for tuberculosis treatment in Brazilian municipalities. The understanding of this process may identify areas with poor adhesion to the new intervention and eventually guide the MoH in future implementation of health programs and policies in the country.

Methods
=======

The analysis unit of this ecological study is the Brazilian municipalities. Data from the Brazilian Case Notification Database (SINAN-Tuberculosis) were used. All municipalities with at least one tuberculosis case notified at SINAN were considered eligible. Population size estimates were those calculated by the Brazilian Geography and Statistics Institute (IBGE) and are available on the Informatics Department of the Brazilian National Health System's website (<http://www.datasus.gov.br>). Patient records from SINAN database include which drugs were used but not the regimen (i.e., whether FDC was in use). Thus, new adolescent and adult (\>10 years) cases notified between December 2009 and March 2011 using the four drugs (R, H, Z and E) after the starting month of implementation of the FDC-RHZE, as informed by the State Health Secretaries, were considered as users of the new FDC-RHZE regimen. We performed an initial quality evaluation on this data frame, aiming to identify data completeness, errors and inconsistencies. We concluded that the database was adequate for the present analysis \[[@B7]\].

The following epidemiological and demographic municipal explanatory factors were analyzed: *i-* population size, *ii-* population density and *iii-* tuberculosis incidence (absolute number of cases and notification rate). Operational health unit explanatory factors included other NTCP recommendations \[[@B1]\]: *i-* use of directly observed treatment (DOT-), *ii-* bacteriological confirmation of cases (positive sputum smear or culture for *M. tuberculosis*) and *iii-* bacteriologic monitoring of treated cases (monthly sputum smear). We initially evaluated two outcomes: *i-* period of onset of the new regimen implementation and *ii-* implementation speed, i.e., the duration of time until maximum coverage (100%) of the new regimen was reached. After an initial exploratory analysis with three ranges (≤2 months, 2--4 months and ≥ 4 months), we chose to work with a 3 month cut-off. Rapid implementation was defined as up to three months (≤3 months) from the onset to maximum coverage. This period can be considered adequate for the Brazilian health system based on its decentralized structure.

Exploratory data analysis also evaluated the distribution of the socio-demographic, epidemiological and operational health service performance variables. We used the odds ratio (OR) to compare the groups of interest. We obtained crude and adjusted estimates in single and multiple regression models using the STATA 10.0 software \[[@B14]\]. The 95% confidence intervals (CI) was calculated using the Mantel-Hanszel method. Explanatory variables with a marginal association with the outcome (p≤0.20) in the bivariate analysis were included into the multiple regression model.

This study was approved by the Institutional Review Board of the Social Medicine Institute (process n° 0024.0.259.000-11) and by the National Committee of Ethics in Research (CONEP, process n°16776).

Results
=======

The municipalities' characteristics are described in Table [1](#T1){ref-type="table"}. Sixty-nine percent (3,826) of Brazilian municipalities were included. Over 70% implemented the new regimen between the 4^th^ quarter of 2009 and the 1^st^ quarter of 2010; 45% reached maximum coverage in less than two months (Table [1](#T1){ref-type="table"}).

###### 

Characteristics of the municipalities that implemented the FDC-RHZE regimen in Brazil

  **Characteristics**                                         **n**   **%**
  ---------------------------------------------------------- ------- -------
  Time to achieve maximum coverage by the FDC-RHZE regimen               
    Less than 2 months                                        1722    45.0
    2 to 4 months                                              599    15.7
    More than 4 months                                        1505    39.3
  Period of onset of the FDC-RHZE regimen implementation                 
    4^th^ quarter 2009 to 1^st^ quarter 2010                  2734    71.5
    2^nd^ quarter 2010 to 3^rd^ quarter 2010                   734    19.2
    4^th^ quarter 2010 to 1^st^ quarter 2011                   358     9.3
  Population of municipalities                                           
    Less than 10,000 inhabitants                              1062    27.8
    10,000-50,000 inhabitants                                 2156    56.3
    50,000-250,000 inhabitants                                 509    13.3
    250,000-500,000 inhabitants                                61      1.6
    More than 500,000 inhabitants                              38      1.0
  Classification of the population density                               
    Less than 11 inhabitants/km^2^                             817    21.4
    11-22 inhabitants/km^2^                                    736    19.2
    22-44 inhabitants/km^2^                                    906    24.0
    44-88 inhabitants/km^2^                                    609    16.0
    More than 88 inhabitants/km^2^                             755    19.4
  Level of incidence                                                     
    Very low \< 10/100,000                                     523    13.7
    Low 10-25/100,000                                         1081    28.2
    Intermediate 25-50/100,000                                1329    34.7
    High 50-100/100,000                                        667    17.4
    Very high \>100/100,000                                    226     6.0
  Proportion of cases in DOT\*                                           
    Very low \<20%                                             114     3.0
    Low 20-40%                                                 36      1.0
    Intermediate 40-60%                                        55      1.4
    High 60-80%                                                88      2.3
    Very high \>80%                                           3533    92.3
  Laboratory confirmation of diagnosis                                   
    Very low \<20%                                             574    15.0
    Low 20-40%                                                 323     8.4
    Intermediate 40-60%                                        672    17.5
    High 60-80%                                                784    20.5
    Very high \>80%                                           1473    38.6
  Laboratory monitoring                                                  
    Very low \<20%                                             983    25.7
    Low 20-40%                                                 310     8.2
    Intermediate 40-60%                                        567    14.8
    High 60-80%                                                633    16.5
    Very high \>80%                                           1333    34.8

\* DOT- Directly observed treatment.

Few municipalities (2%) have more than 250,000 inhabitants, one-fifth have a high population density (over 88 inhabitants per km^2^) and the same proportion has a density lower than 11 inhabitants per km^2^.

Most of the municipalities had a low or intermediate incidence rate. Noteworthy, more than 90% of municipalities have a very high proportion (more than 80%) of cases under DOT (Table [1](#T1){ref-type="table"}).

Over half of the municipalities perform laboratory confirmation for tuberculosis in more than 60% of diagnosed cases. As for laboratory monitoring of treated cases, 34% perform in less than 40% of cases and a similar proportion in more than 80% of cases (Table [1](#T1){ref-type="table"}).

Because the onset date of implementation did not have a clear trend, and no relationship was detected between the explanatory factors and the onset of the implementation (data not shown), only rapid implementation was analyzed as the outcome in the present study.

Table [2](#T2){ref-type="table"} presents demographic, epidemiological and operational performance characteristics according to the time to reach maximum coverage of the new RHZE-FDC regimen. The more populated the municipalities are, the longer it takes to reach maximum coverage. Conversely, the higher the demographic density and incidence rates, the slower the implementation. Based on this exploratory analysis, the cut-off points of the independent variables were set as shown in Table [3](#T3){ref-type="table"}.

###### 

Epidemiological characteristics and NTP performance according to the time to full implementation of the FDC-RHZE regimen in Brazil

  **Characteristics**                                                  **Time to full implementation of FDC-RHZE regimen in Brazil**                  
  ------------------------------------------------------------------- --------------------------------------------------------------- ------- ------- -------
  Demographic and epidemiological                                                                                                                         
   Size population (mean)                                                                          11756                               17941   98974   47032
   Population density (mean)                                                                       35.2                                46.4    313.2   146.4
   Tuberculosis incidence rate\* 2010 (mean)                                                       25.3                                32.2    67.3    42.9
  Operational NTP\*\*                                                                                                                                     
   Proportion of patients with DOT\*\*\* (mean)                                                    96.4                                95.5    92.4    94.7
   Proportion of patients with confirmatory laboratory tests (mean)                                60.6                                62.7    64.6    62.5
   Proportion of patients with follow-up laboratory tests (mean)                                   49.6                                59.0    59.6    55.0

\* Rate per 100 hundred inhabitants; \*\*NTP-National tuberculosis program; \*\*\*DOT-directly observed treatment.

###### 

Factors associated with a short time (≤ 3 months) to full implementation of the FDC-RHZE regimen in Brazil

  **Factors**                                          **Crude odds ratio**     **95% CI**      **Adjusted odds ratio**    **95% CI**
  --------------------------------------------------- ---------------------- ----------------- ------------------------- ---------------
  Small population (\< 10,000)                                                                                                   
   No                                                           1                                          1                     
   Yes                                                        16.84           13.39 -- 21.17             25.52            19.09- 34.10
  Low population density (\<88 inhabitants /km^2^)                                                                               
   No                                                           1                                          1                     
   Yes                                                         5.64            4.68 -- 6.80              2.33             1.87 -- 2.91
  Low level of incidence TB (\<50/100,000)                                                                                       
   No                                                           1                                          1                     
   Yes                                                         4.21            3.57 -- 4.96              8.79             6.75 -- 11.45
  High coverage DOT\* (\>80%)                                                                                                    
   No                                                           1                                          1                     
   Yes                                                         2.30            1.79 -- 2.95              1.55             1.14 -- 2.12
  High laboratory confirmation pulmonary TB (\>80%)                                                                              
   No                                                           1                                          1                     
   Yes                                                         2.12            1.85 -- 2.42              1.93             1.63 -- 2.29
  High laboratory monitoring (\>80%)                                                                                             
   No                                                           1                                          1                     
   Yes                                                         1.45            1.27 -- 1.67              0.92             0.78 -- 1.09
  Less than 120 patients treated                                                                                                 
   No                                                           1                                          1                     
   Yes                                                        134.26          18.73 -- 962.41            10.07            1.36 -- 74.52

\* DOT- Directly observed treatment.

Operational health service performance characteristics, such as more laboratory confirmation and monitoring of cases, were associated with a more rapid implementation. However, the inverse relationship occurs for the proportion of cases under DOT (Table [2](#T2){ref-type="table"}). In the multivariate context, the association between speed and laboratory monitoring has lost statistical significance (Table [3](#T3){ref-type="table"}). The variable "high laboratory monitoring (\>80%)" was not associated in the multiple regression analysis. Thus, it was excluded from the final model.

Discussion
==========

The understanding of the process of adoption of any new health technology becomes highly important for tuberculosis services as new diagnostic tests \[[@B15]\], treatment regimens \[[@B16]\] and vaccines \[[@B17]\] are expected to emerge in the next few years, after decades of stagnation. How to evaluate these processes, however, is a challenge. Habicht et al. (1999) \[[@B18]\] revised the design options to evaluate public health program performance. They enumerate, as indicators of performance: adequacy, provision, utilization, coverage and impact. The authors also point out that specific interventions should be evaluated considering the initially planned implementation schedule. In the present study, we chose to analyze the time till full coverage of the implementation of a new treatment recommendation in different municipalities in Brazil using secondary data. This was only possible because notification of tuberculosis is mandatory in the country.

Elmahalli et al. (2010) \[[@B19]\] assessed the implementation of DOTS strategy in two chest facilities in Alexandria, Egypt, using treatment success as the outcome. They argue that operational indicators, such as treatment outcome, can be considered excellent tools for monitoring the process of tuberculosis care, especially in developing countries. Although we agree that these are useful indicators of program performance, they are less appropriate to study the implementation process of a new recommendation. In our study, we preferred, instead, to study the implementation process of the new treatment regimen using a different approach, since other relevant data were available in the Brazilian surveillance system.

The implementation of new tuberculosis treatments, including MDR-TB treatment, was reported in different countries \[[@B20]\]. However, these analyses were essentially descriptive. To our knowledge, there are no previous studies addressing factors associated with the implementation process measured as the time to reach full coverage. In the present study, we addressed the factors associated with the time to full coverage of new regimen implementation process. Almost 70% of Brazilian municipalities had notified at least one case of tuberculosis in the study period, which reflects on one hand, the extent of the disease in the country and on the other hand, the expansion of tuberculosis diagnostic activities. Demographic and epidemiological factors as well as operational factors influenced rapid implementation. Among them, demographic factors had the higher magnitude of association. Municipalities characteristics such as population size, demographic density and incidence rates were associated with the rapid implementation of the new regimen. Although in a smaller magnitude, compliance to some NTCP recommendations, such as DOT and microbiological confirmation of cases, also were associated with rapid implementation.

Larger municipalities generally have health systems with many facilities, which need more human resources and health infrastructure, more complex public health program management. They also have populations with a high heterogeneity concerning access to diagnosis and tuberculosis treatment services, which may explain the more rapid implementation in smaller municipalities. This explanation is corroborated by a recent study in Recife, a large city in the Northeast of Brazil, where the incomplete implementation of the epidemiological surveillance management was explained by lack of human resources and incipient performance of planning and Monitoring & Evaluation activities \[[@B21]\]. Likewise, the Family Health Program implementation in Santa Catarina, a wealthy and developed state in Southern Brazil, was firstly implanted in areas less assisted, in small or medium size municipalities, where financial incentive to the program induced rapid implementation. Indeed, one or two family health teams offers high coverage rates in municipalities with up to 10,000 inhabitants \[[@B22]\].

Regardless of the population size, demographic density also delayed the implementation of the new treatment. Poor social condition found in situations of intense urban agglomerations possibly hamper access to health services. It is intuitive to expect that municipalities with small populations or a small number of cases have easier access to new regimens. Areas with large number of cases demand more health units and higher number of trained professionals. On the other hand, higher incidence rates are usually found in situations of worse health policy performance. Lack of professionals, transport problems and insufficient resources for technical assistance were considered the major barriers for tuberculosis control in São José do Rio Preto, a medium size municipality \[[@B22]\].

In the present study, operational indicators such as DOT coverage and microbiological confirmation of diagnosis, as recommended by the NTCP guidelines, were independently associated to rapid implementation of the new regimen. This may reflect willingness, commitment and capacity of municipal TCP in lining-up with new recommendations from the NTCP. None of those different operational aspects represent by themselves a construct regarding the quality of tuberculosis control actions practiced at the municipal level. However, the independent association of those factors indicates that they evaluate different aspects of the same commitment.

Other factors possibly associated with rapid implementation of the new regimen, mainly those related to health service organization (human resources, decentralization of care, municipal tuberculosis control program structure among others), were not considered due to the nature of this study, which used secondary data from the tuberculosis surveillance system. The quality of this database may have influenced the results of this study. Thus, a previous evaluation was done to ensure the quality of the data \[[@B7]\]. Other possible limitations of this study may result from classification of individuals regarding the use of the new regimen, which was based on the use of 4 drugs in new cases, instead of the use of FDCs, since the latter information is not available. This may have overestimated the coverage of the new regimen, but is not likely to have influenced the evaluation of the implementation speed.

Conclusions
===========

The analysis of the Brazilian surveillance secondary database made possible the evaluation of the implementation process of a new tuberculosis treatment regimen in this continental-sized country, measured by the length of time to reach full coverage. This analytical approach is useful to learn lessons. It was possible to demonstrate that demographic and operational characteristics of municipalities have influenced the implementation process. Municipalities with larger population size, higher demographic density and higher incidence rates may need more attention for the implementation of future new guidelines for tuberculosis control as well as for other diseases. Effectiveness studies are necessary and may be performed using the same methodology.
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